Expanded Access Program for Aztreonam Lysine for Inhalation in Canadian Patients With Cystic Fibrosis

NCT00989807 · clinicaltrials.gov ↗

APPROVED_FOR_MARKETING

Status

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis
Pseudomonas Aeruginosa

Interventions

DRUG: Aztreonam lysine

Sponsor

Gilead Sciences